Evidence map›Paper›PMID 29496995›Full record

ArticleThe Journal of biological chemistry2018

Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: A potential carbamylation route involved in the formation of atherosclerotic plaques?

Cédric Delporte, Karim Zouaoui Boudjeltia, Paul G Furtmüller, Richard A Maki, Marc Dieu, Caroline Noyon, Monika Soudi, Damien Dufour, Catherine Coremans, Vincent Nuyens and 12 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. A guide to uraemic toxicity.Nature reviews. Nephrology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Halogenation Activity of Mammalian Heme Peroxidases.Antioxidants (Basel, Switzerland) · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 5 countries.

Cédric DelporteFrom the Laboratory of Pharmaceutical Chemistry and.ORCID 0000-0001-7453-7028
Karim Zouaoui Boudjeltiathe Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, 6110 Montigny-le-Tilleul, Belgium.
Paul G Furtmüllerthe Department of Chemistry, Division of Biochemistry, University of Natural Resources and Life Sciences (BOKU), 1180 Vienna, Austria.ORCID 0000-0002-1199-2469
Richard A MakiTorrey Pines Pharmaceuticals, Del Mar, California 92014.ORCID 0000-0002-9593-0723
Marc Dieuthe Laboratory of Cellular Biology and.
Caroline NoyonFrom the Laboratory of Pharmaceutical Chemistry and.ORCID 0000-0002-1505-4541
Monika Soudithe Department of Chemistry, Division of Biochemistry, University of Natural Resources and Life Sciences (BOKU), 1180 Vienna, Austria.
Damien DufourFrom the Laboratory of Pharmaceutical Chemistry and.
Catherine CoremansFrom the Laboratory of Pharmaceutical Chemistry and.
Vincent Nuyensthe Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, 6110 Montigny-le-Tilleul, Belgium.
Florence ReyeFrom the Laboratory of Pharmaceutical Chemistry and.
Alexandre Rousseauthe Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, 6110 Montigny-le-Tilleul, Belgium.
Martine Raesthe Laboratory of Cellular Biology and.
Nicole MoguilevskyTechnology Transfer Office, University of Namur, 5000 Namur, Belgium.
Michel Vanhaeverbeekthe Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, 6110 Montigny-le-Tilleul, Belgium.
Jean Ducobuthe Laboratory of Experimental Medicine, CHU de Charleroi, A. Vésale Hospital, Université Libre de Bruxelles, 6110 Montigny-le-Tilleul, Belgium.
Jean NèveFrom the Laboratory of Pharmaceutical Chemistry and.
Bernard Robayethe Institute of Interdisciplinary Research, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Faculty of Sciences, Université Libre de Bruxelles, 6041 Gosselies, Belgium, and.
Luc Vanhammethe Laboratory of Molecular Parasitology, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Faculty of Sciences, Université Libre de Bruxelles, 6041 Gosselies, Belgium.
Wanda F Reynoldsthe Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California 92037.
Christian Obingerthe Department of Chemistry, Division of Biochemistry, University of Natural Resources and Life Sciences (BOKU), 1180 Vienna, Austria.ORCID 0000-0002-7133-3430
Pierre Van AntwerpenFrom the Laboratory of Pharmaceutical Chemistry and pvantwer@ulb.ac.be.ORCID 0000-0002-4934-8863
Université Libre de Bruxelles · BEBOKU University · ATPharmaceutical Biotechnology (Czechia) · CZUniversity of Namur · BESanford Burnham Prebys Medical Discovery Institute · US

Funding

MPO oxidants in synucleinopathiesR01NS074303 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI REYNOLDS, WANDA F · 2011 to 2015
$1.9M
Development of Myeloperoxidase Inhibitors to Treat Alzheimer's DiseaseR43AG040935 · NIA · TORREY PINES PHARMACEUTICALS, INC. · PI MAKI, RICHARD ALLAN · 2012 to 2013
$521k
Austrian Science Fund FWF W 1224NIA NIH HHS R43 AG040935NINDS NIH HHS R01 NS074303
6 · The paper itself

Abstract

Protein carbamylation by cyanate is a post-translational modification associated with several (patho)physiological conditions, including cardiovascular disorders. However, the biochemical pathways leading to protein carbamylation are incompletely characterized. This work demonstrates that the heme protein myeloperoxidase (MPO), which is secreted at high concentrations at inflammatory sites from stimulated neutrophils and monocytes, is able to catalyze the two-electron oxidation of cyanide to cyanate and promote the carbamylation of taurine, lysine, and low-density lipoproteins. We probed the role of cyanide as both electron donor and low-spin ligand by pre-steady-state and steady-state kinetic analyses and analyzed reaction products by MS. Moreover, we present two further pathways of carbamylation that involve reaction products of MPO, namely oxidation of cyanide by hypochlorous acid and reaction of thiocyanate with chloramines. Finally, using an

Indexed as

CyanatesCyanidesPeroxidaseProtein CarbamylationAnimalsCitrullineHumansMiceMice, KnockoutOxidation-ReductionPlaque, AtheroscleroticCitrullineCyanatesCyanideshomocitrullineMPO protein, humanPeroxidaseatherosclerosiscardiovascular diseasecyanatecyanidelipoproteinmyeloperoxidasepost-translational modification (PTM)

Identifiers

PMID29496995
PMCPMC5925816
OpenAlexW2791572784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.